Safety and Tuberculin Conversion Following BCG Vaccination

Clinical trial NCT05124340 · COMPLETED

Trial details

NCT number: NCT05124340
Sponsor: PT Bio Farma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

BCG Vaccination Reaction

Start date: 2021-12-01
Primary completion: 2022-05-31
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.